Observes dissolving magnesium stents in people with coronary artery disease
Follows people with coronary artery disease treated with dissolving magnesium heart stents.
Plain-language title generated from the registry record
Registry title: Resorbable Magnesium Scaffolds Registry
Key facts
- Where
- Lublin, PolandSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with coronary artery disease who are treated with a resorbable magnesium scaffold (Magmaris or Freesolve), used as the device instructions describe.
- Age
- 18 years and older
- Sex
- All sexes can join
Main reasons for not taking part
- The record only says the exclusions follow the device instructions for use, with no list.
Read by machine on 12 November 2026.
Where in Poland
- 1 Wojskowy Szpital Kliniczny Z Poliklinika SPZOZ W LublinieLublin, PolandContact: Grzegorz Sobieszek, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Biotronik AG
- Trial code
- NCT04679740
- Record updated
- 21 November 2025
- Original description
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).Read full original descriptionShow less
RMS (Resorbable Magnesium Scaffolds) Registry
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
Inclusion: According to the IFU.
Exclusion: According to the IFU.